Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Preprint |
| Published: |
2024
|
| Subjects: | |
| Online Access: | https://arxiv.org/abs/2411.02307 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1866917828102193152 |
|---|---|
| author | Francisco, Kishi Kobe Yee Apuhin, Andrane Estelle Carnicer Tan, Myles Joshua Toledo Byers, Mickael Cavanaugh Maravilla, Nicholle Mae Amor Tan Karim, Hezerul Abdul AlDahoul, Nouar |
| author_facet | Francisco, Kishi Kobe Yee Apuhin, Andrane Estelle Carnicer Tan, Myles Joshua Toledo Byers, Mickael Cavanaugh Maravilla, Nicholle Mae Amor Tan Karim, Hezerul Abdul AlDahoul, Nouar |
| contents | Personalized medicine (PM) promises to transform healthcare by providing treatments tailored to individual genetic, environmental, and lifestyle factors. However, its high costs and infrastructure demands raise concerns about exacerbating health disparities, especially between high-income countries (HICs) and low- and middle-income countries (LMICs). While HICs benefit from advanced PM applications through AI and genomics, LMICs often lack the resources necessary to adopt these innovations, leading to a widening healthcare divide. This paper explores the financial and ethical challenges of PM implementation, with a focus on ensuring equitable access. It proposes strategies for global collaboration, infrastructure development, and ethical frameworks to support LMICs in adopting PM, aiming to prevent further disparities in healthcare accessibility and outcomes. |
| format | Preprint |
| id |
arxiv_https___arxiv_org_abs_2411_02307 |
| institution | arXiv |
| publishDate | 2024 |
| record_format | arxiv |
| spellingShingle | Can Personalized Medicine Coexist with Health Equity? Examining the Cost Barrier and Ethical Implications Francisco, Kishi Kobe Yee Apuhin, Andrane Estelle Carnicer Tan, Myles Joshua Toledo Byers, Mickael Cavanaugh Maravilla, Nicholle Mae Amor Tan Karim, Hezerul Abdul AlDahoul, Nouar Computers and Society Personalized medicine (PM) promises to transform healthcare by providing treatments tailored to individual genetic, environmental, and lifestyle factors. However, its high costs and infrastructure demands raise concerns about exacerbating health disparities, especially between high-income countries (HICs) and low- and middle-income countries (LMICs). While HICs benefit from advanced PM applications through AI and genomics, LMICs often lack the resources necessary to adopt these innovations, leading to a widening healthcare divide. This paper explores the financial and ethical challenges of PM implementation, with a focus on ensuring equitable access. It proposes strategies for global collaboration, infrastructure development, and ethical frameworks to support LMICs in adopting PM, aiming to prevent further disparities in healthcare accessibility and outcomes. |
| title | Can Personalized Medicine Coexist with Health Equity? Examining the Cost Barrier and Ethical Implications |
| topic | Computers and Society |
| url | https://arxiv.org/abs/2411.02307 |